- Home
- THCH vs VTGN Comparison
THCH vs VTGN Comparison
Compare THCH & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THCH
- VTGN
- Stock Information
- Founded
- THCH 2018
- VTGN 1998
- Country
- THCH China
- VTGN United States
- Employees
- THCH N/A
- VTGN N/A
- Industry
- THCH Blank Checks
- VTGN Biotechnology: Pharmaceutical Preparations
- Sector
- THCH Finance
- VTGN Health Care
- Exchange
- THCH Nasdaq
- VTGN Nasdaq
- Market Cap
- THCH 73.0M
- VTGN 62.9M
- IPO Year
- THCH N/A
- VTGN N/A
- Fundamental
- Price
- THCH $2.63
- VTGN $2.24
- Analyst Decision
- THCH
- VTGN
- Analyst Count
- THCH 0
- VTGN 0
- Target Price
- THCH N/A
- VTGN N/A
- AVG Volume (30 Days)
- THCH 9.8K
- VTGN 89.0K
- Earning Date
- THCH 06-04-2025
- VTGN 06-10-2025
- Dividend Yield
- THCH N/A
- VTGN N/A
- EPS Growth
- THCH N/A
- VTGN N/A
- EPS
- THCH N/A
- VTGN N/A
- Revenue
- THCH $190,593,087.00
- VTGN $698,000.00
- Revenue This Year
- THCH N/A
- VTGN N/A
- Revenue Next Year
- THCH N/A
- VTGN N/A
- P/E Ratio
- THCH N/A
- VTGN N/A
- Revenue Growth
- THCH N/A
- VTGN N/A
- 52 Week Low
- THCH $2.15
- VTGN $1.90
- 52 Week High
- THCH $6.00
- VTGN $4.75
- Technical
- Relative Strength Index (RSI)
- THCH 43.75
- VTGN 46.94
- Support Level
- THCH $2.61
- VTGN $2.10
- Resistance Level
- THCH $2.84
- VTGN $2.45
- Average True Range (ATR)
- THCH 0.13
- VTGN 0.13
- MACD
- THCH 0.01
- VTGN 0.02
- Stochastic Oscillator
- THCH 48.94
- VTGN 53.33
About THCH TH International Limited Ordinary shares
TH International Ltd is the parent company of the franchise of Tim Hortons coffee shops and has the rights to operate Tim Hortons coffee shops in mainland China, Hong Kong, and Macau. Through the Tim Hortons brand, the firm offers freshly brewed coffee, tea, and other beverages, bakery & sides, and sandwiches. It is also the operator and developer of Popeyes brand in Mainland China. The firm has two reportable segments; Tim Hortons which generates key revenue, and Popeyes. The company's revenue is derived from its operations in the PRC.
About VTGN VistaGen Therapeutics Inc.
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.